Pre-Clinical Consulting Services
Closed Pre-Solicitation Posted
- Solicitation number
- 75N95025Q00127_SB
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, is seeking pre-clinical consulting services through a small business sources sought notice. The contractor will provide consulting expertise for the Clinical Trials Unit (CTU), supporting clinical research and pre-clinical development initiatives. Required qualifications include extensive experience working with the American Society for Experimental Therapeutics (ASENT), pharmaceutical industry, academics, and demonstrated expertise in clinical research regulatory and gene-therapy domains. Interested small businesses must submit detailed 10-page capability statements electronically to Frederick Weddington by January 17, 2025, at 9:00 am ET. The evaluation will focus on professional qualifications, employee capabilities, GSA Schedule contracts, and comprehensive understanding of the complex consulting requirements.
The opportunity is specifically set aside for small businesses under NAICS code 541690, with a size standard of $19M for Other Scientific and Technical Consulting Services. Services will be performed virtually through NINDS IT resources at the Bethesda campus in Maryland, with points of contact including Dr. Lauren Reoma and Mr. Bradley Alvarez. While the precise contract value is not specified, the solicitation supports over 120 clinical research programs and seeks to advance clinical trial methodology through collaborative partnerships. The CTU aims to ensure quality practice in intramural research programs by securing high-level consulting expertise. The timeline for services remains to be determined (TBD), indicating flexibility in contract execution and potential scope of work.
Notice text
Pre-Clinical Consulting Services
Files
| File | Type | Posted |
|---|---|---|
| B. Sources Sought Notice - (SB).pdf | ||
| Statement of Work.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| 2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services | — | Total Small Business | |
| ATT 1 Senior _Advisor_2026_Statement of Work - Biological therapeutics EOC Support- 7571PS27Q00017 | — | Total Small Business | |
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity